Dr. Vlad C. Vasile, MD

Dr. Vasile practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Vasile's NPI, 1740544675, was assigned on June 26, 2012. Dr. Vasile graduated from Carol Davila University of Medicine and Pharmacy in 1999. Dr. Vasile holds Minnesota license 58254.

Dr. Vasile's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Vasile's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Vasile to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vasile practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Vasile's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Vasile is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Vasile is licensed in Minnesota.

Dmand AI lists aneurysm, angioplasty, atherosclerosis, cardiac arrhythmia, chronic hypertension, congestive heart failure, coronary artery disease and heart attack among the conditions Dr. Vasile treats.

CMS data shows 996 Medicare services from Dr. Vasile across 8 procedure codes in 2024, for 411 Medicare patients. Medicare paid $21,039 for them.

CMS counts 411 Medicare patients who saw Dr. Vasile in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vasile's median patient age at 59, with 37% women.

In 2024, Dr. Vasile wrote 120 Medicare Part D claims for 35 patients. 55% of them were for generic drugs. CMS names the drug for 78 of them, across 4 drugs with 11 or more claims each, at $32,830 in total drug cost. In 2023, CMS named 138 claims across 6 drugs.

Dr. Vasile accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vasile as offering telehealth.

Dmand AI links 36 papers to Dr. Vasile, published from 2006 to 2024. 2020 was the busiest year, with 6. The most frequent topics are Myocardial Infarction, Troponin T and Ceramides. Dr. Vasile has published most often in Clin Chem. Dr. Vasile's most frequent co-authors are Allan S. Jaffe, MD, Stephen L. Kopecky, MD and Michael J. Ackerman, MD.

CMS Open Payments shows 13 general payments to Dr. Vasile from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 59% of the total. Siemens Medical Solutions USA, Inc. paid the most, $164.

Dr. Vasile graduated from Carol Davila University of Medicine and Pharmacy in 1999.

Dr. Vasile is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.